Cancer Research Technology
Log in Register
Menu

Anti-VEGF [VG76e]

Invented by Prof Roy Bicknell at University of Oxford

Info

Catalogue Number 151223
Applications ELISA IHC WB
Antigen/Gene or Protein Targets Vascular Endothelial Growth Factor (VEGF)
Reactivity Human, Mouse and Primate
Relevance Monoclonal antibody with use investigating MVCD1, angiogenesis and various cancers.

Background and Research Application
VEGF is a 34-43 kD polypeptide growth factor, part of the PDGF family. There are 7 homo-dimeric isoforms (A-G) with VEGF 121, VEGF 165 and VEGF189 being the most extensively studied (F,D and B respectively). They are generated by alternative splicing and binding to VEGF receptors (FLT-1 and KDR) which are selectively expressed on vascular endothelial cells. VEGF elicits mitogenic effects on endothelial cells and is strongly angiogenic, with a role in cancer and metastasis. VEGF is involved in vasculogenesis and endothelial growth. VEGF expression is potentiated, and the protein is secreted by tumour cells in response to hypoxia, by activated oncogenes, growth factors, nitric oxide and a variety of cytokines. Defects in VEGFA are linked to MVCD1 (microvascular complications of diabetes type 1) and VEGF polymorphisms are associated with susceptibility to multiple cancers, e.g. glioma, HCC, ovarian, bladder, prostate, breast cancer etc.
VEGF is an angiogenic growth factor and a prognostic indicator for cancer when detected in serum.
This antibody binds VEGF-A.
Host Mouse
Immunogen Human VEGF189 expressed in E. coli.
Immunogen UniProt ID P15692
Positive Control VEGF recombinant protein.
Subclass IgG1 kappa
Molecular Weight (kDa) 38-44
Myeloma Used P3/NS1/1-Ag4.1
Recommended Growing Conditions DMEM + 10% FCS
Notes Production Details
Purified using multi-step affinity chromatography with protein A.

Storage Conditions
Store at -20 degrees frozen. Avoid repeated freeze/thaw cycles.

Points of Interest
VG76e will detect both native and denatured protein

Concentration
1mg/ml as standard
Research Area Cancer, Cardiovascular, Cell Signaling & Signal Transduction, Metabolism

References

There are 17 reference entries for this reagent.

View All References

References: 17 entries

Kimoto et al. 2019. Nucleic Acids Res. 47(16):8362-8374. PMID: 31392985.

Tan et al. 2017. Sci Rep. 7(1):3504. PMID: 28615707.

Leonhäuser et al. 2017. J Transl Med. 15(1):3. PMID: 28049497.

Butler et al. 2011. Am J Physiol Cell Physiol. 301(3):C653-66. PMID: 21653901.

Contributions of VEGF to age-dependent transmural gradients in contractile protein expression in ovine carotid arteries.

Europe PMC ID: 21653901

de Queiroz et al. 2010. J Vet Diagn Invest. 22(1):105-8. PMID: 20093695.

Vascular endothelial growth factor expression and microvascular density in soft tissue sarcomas in dogs.

Europe PMC ID: 20093695

Mariani et al. 2006. Theriogenology. 66(6-7):1715-20. PMID: 16569426.

Immunohistochemical localization of VEGF and its receptors in the corpus luteum of the bitch during diestrus and anestrus.

Europe PMC ID: 16569426

Brown et al. 2005. Br J Cancer. 92(9):1696-701. PMID: 15841086.

Cooperative stimulation of vascular endothelial growth factor expression by hypoxia and reactive oxygen species: the effect of targeting vascular endothelial growth factor and oxidative stress in an orthotopic xenograft model of bladder carcinoma.

Europe PMC ID: 15841086

Bouziotis et al. 2003. Anticancer Res. 23(3A):2167-71. PMID: 12894592.

Samarium-153 and technetium-99m-labeled monoclonal antibodies in angiogenesis for tumor visualization and inhibition.

Europe PMC ID: 12894592

Zhang et al. 1998. J Pathol. 185(4):402-8. PMID: 9828839.

Validation of anti-vascular endothelial growth factor (anti-VEGF) antibodies for immunohistochemical localization of VEGF in tissue sections: expression of VEGF in the human endometrium.

Europe PMC ID: 9828839

Epstein et al. 1975. J Am Podiatry Assoc. 65(12):1131-6. PMID: 1238455.

Malpractice and PSROs.

Europe PMC ID: 1238455


Add a reference

References: 17 entries

Kimoto et al. 2019. Nucleic Acids Res. 47(16):8362-8374. PMID: 31392985.

Tan et al. 2017. Sci Rep. 7(1):3504. PMID: 28615707.

Leonhäuser et al. 2017. J Transl Med. 15(1):3. PMID: 28049497.

Butler et al. 2011. Am J Physiol Cell Physiol. 301(3):C653-66. PMID: 21653901.

Contributions of VEGF to age-dependent transmural gradients in contractile protein expression in ovine carotid arteries.

de Queiroz et al. 2010. J Vet Diagn Invest. 22(1):105-8. PMID: 20093695.

Vascular endothelial growth factor expression and microvascular density in soft tissue sarcomas in dogs.

Mariani et al. 2006. Theriogenology. 66(6-7):1715-20. PMID: 16569426.

Immunohistochemical localization of VEGF and its receptors in the corpus luteum of the bitch during diestrus and anestrus.

Brown et al. 2005. Br J Cancer. 92(9):1696-701. PMID: 15841086.

Cooperative stimulation of vascular endothelial growth factor expression by hypoxia and reactive oxygen species: the effect of targeting vascular endothelial growth factor and oxidative stress in an orthotopic xenograft model of bladder carcinoma.

Bouziotis et al. 2003. Anticancer Res. 23(3A):2167-71. PMID: 12894592.

Samarium-153 and technetium-99m-labeled monoclonal antibodies in angiogenesis for tumor visualization and inhibition.

Zhang et al. 1998. J Pathol. 185(4):402-8. PMID: 9828839.

Validation of anti-vascular endothelial growth factor (anti-VEGF) antibodies for immunohistochemical localization of VEGF in tissue sections: expression of VEGF in the human endometrium.

Epstein et al. 1975. J Am Podiatry Assoc. 65(12):1131-6. PMID: 1238455.

Malpractice and PSROs.


Add a reference